Protection against arsenic trioxide-induced autophagic cell death in U118 human glioma cells by use of lipoic acid

Food and Chemical Toxicology

Volumn 45, Issue 6, 2007, Pages 1027-1038

  Cheng, Tain Junn ^a,b   Wang, Ying Jan ^b   Kao, Wei Wan ^b   Chen, Rong Jane ^b   Ho, Yuan Soon ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Arsenic trioxide; Autophage; Lipoic acid; Neurotoxicity

Indexed keywords

ACRIDINE ORANGE; ARSENIC TRIOXIDE; GROUND WATER; HEAT SHOCK PROTEIN 70; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; THIOCTIC ACID;

ANTIOXIDANT ACTIVITY; ARTICLE; AUTOPHAGY; BRAIN DAMAGE; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GLIOMA CELL; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; NEUROPROTECTION; NEUROTOXICITY; STAINING; UPREGULATION; WESTERN BLOTTING;

ACRIDINE ORANGE; ANTIOXIDANTS; APOPTOSIS REGULATORY PROTEINS; ARSENIC POISONING; ARSENICALS; AUTOPHAGY; BLOTTING, WESTERN; CELL LINE, TUMOR; DRUG INTERACTIONS; ELECTROPHORESIS, AGAR GEL; FLOW CYTOMETRY; FLUORESCENT DYES; GLIOMA; HUMANS; NEUROGLIA; OXIDES; THIOCTIC ACID;

ANIMALIA;

EID: 33947725524     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2006.12.014     Document Type: Article

References (56)

1. Basun H., Forssell L.G., Wetterberg L., and Winblad B. Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. Journal of Neural Transmission Parkinsons Disease and Dementia Section 3 4 (1991) 231-258
2. Chattopadhyay S., Bhaumik S., Nag Chaudhury A., and Das Gupta S. Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicology Letters 128 1-3 (2002) 73-84
3. 3). FEBS Letters 519 1-3 (2002) 195-200
4. Filippova M., and Duerksen-Hughes P.J. Inorganic and dimethylated arsenic species induce cellular p53. Chemical Research in Toxicology 16 3 (2003) 423-431
5. Fujino Y., Guo X., Liu J., You L., Miyatake M., Yoshimura T., and Japan Inner Mongolia Arsenic Pollution Study Group. Mental health burden amongst inhabitants of an arsenic-affected area in Inner Mongolia, China. Social Science and Medicine 59 9 (2004) 1969-1973
6. Gamalei I.A., Kirpichnikova K.M., Ishchenko A.M., Zhakhov A.V., and Kliubin I.V. Activation of astrocytes of by anaphylatoxins of the complement system. Tsitologiia 40 8-9 (1998) 768-772
7. 3 is associated with the inherent cellular level of reactive oxygen species. World Journal of Gastroenterology 8 1 (2002) 36-39
8. Grant S., Turner A.J., Bartimole T.M., Nelms P.A., Joe V.C., and Jarvis W.D. Modulation of 1-[beta-d-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C. Oncology Research 6 2 (1994) 87-99
9. Greggi Antunes L.M., Darin J.D., and Bianchi M.D. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacological Research 41 4 (2000) 405-411
10. 3)-induced apoptosis in human glioblastoma cells. Cancer Science 96 11 (2005) 825-833
11. Hall A.H. Chronic arsenic poisoning. Toxicology Letters 128 1-3 (2002) 69-72
12. Hantson P., Haufroid V., Buchet J.P., and Mahieu P. Acute arsenic poisoning treated by intravenous dimercaptosuccinic acid (DMSA) and combined extrarenal epuration techniques. Journal of Toxicology Clinical Toxicology 41 1 (2003) 1-6
13. Ho Y.S., Wang Y.J., and Lin J.K. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells. Molecular Carcinogenesis 16 1 (1996) 20-31
14. Jiang X.H., Wong B.C., Yuen S.T., Jiang S.H., Cho C.H., Lai K.C., Lin M.C., Kung H.F., and Lam S.K. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. Erratum appears in Int J Cancer 2001 September 15;93(6):916 Note: Chun-Yu Wong B [corrected to Wong BC]. International Journal of Cancer 91 2 (2001) 173-179
15. Kanzawa T., Kondo Y., Ito H., Kondo S., and Germano I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Research 63 9 (2003) 2103-2108
16. Kanzawa T., Zhang L., Xiao L., Germano I.M., Kondo Y., and Kondo S. Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 24 6 (2005) 980-991
17. Karlsson J.I.O.R., Porn-Ares I., and Pahlman S. Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53. Clinical Cancer Research 10 9 (2004) 3179-3188
18. Kato K., Ito H., and Okamoto K. Modulation of the arsenite-induced expression of stress proteins by reducing agents. Cell Stress and Chaperones 2 3 (1997) 199-209
19. Kim S.U., and de Vellis J. Microglia in health and disease. Journal of Neuroscience Research 81 3 (2005) 302-313
20. Kim K.B., Bedikian A.Y., Camacho L.H., Papadopoulos N.E., and McCullough C. A phase II trial of arsenic trioxide in patients with metastatic melanoma. Cancer 104 8 (2005) 1687-1692
21. Kozlov A.V., Gille L., Staniek K., and Nohl H. Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and one-electron reduction of ubisemiquinone. Archives of Biochemistry and Biophysics 363 1 (1999) 148-154
22. Larsen N.A., Pakkenberg H., Damsgaard E., Heydorn K., and Wold S. Distribution of arsenic, manganese, and selenium in the human brain in chronic renal insufficiency, Parkinson's disease, and amyotrophic lateral sclerosis. Journal of the Neurological Sciences 51 3 (1981) 437-446
23. Lee Y.W., Ha M.S., and Kim Y.K. Role of reactive oxygen species and glutathione in inorganic mercury-induced injury in human glioma cells. Neurochemical Research 26 11 (2001) 1187-1193
24. Lee W.S., Chen R.J., Wang Y.J., Tseng H., Jeng J.H., Lin S.Y., Liang Y.C., Chen C.H., Lin C.H., Lin J.K., Ho P.Y., Chu J.S., Ho W.L., Chen L.C., and Ho Y.S. In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest. International Journal of Cancer 106 1 (2003) 125-137
25. Liang X.Q., Cao E.H., Zhang Y., and Qin J.F. P53-induced gene 11 (PIG11) involved in arsenic trioxide-induced apoptosis in human gastric cancer MGC-803 cells. Oncology Reports 10 5 (2003) 1265-1269
26. Liu J.D., Wang Y.J., Chen C.H., Yu C.F., Chen L.C., Lin J.K., Liang Y.C., Lin S.Y., and Ho Y.S. Molecular mechanisms of G0/G1 cell-cycle arrest and apoptosis induced by terfenadine in human cancer cells. Molecular Carcinogenesis 37 1 (2003) 39-50
27. 3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Research 61 14 (2001) 5432-5440
28. McCarty M.F. Versatile cytoprotective activity of lipoic acid may reflect its ability to activate signalling intermediates that trigger the heat-shock and phase II responses. Medical Hypotheses 57 3 (2001) 313-317
29. Meijer A.J., and Codogno P. Regulation and role of autophagy in mammalian cells. International Journal of Biochemistry and Cell Biology 36 12 (2004) 2445-2462
30. Mizushima N., Noda T., Yoshimori T., Tanaka Y., Ishii T., George M.D., Klionsky D.J., Ohsumi M., and Ohsumi Y. A protein conjugation system essential for autophagy. see comment. Nature 395 6700 (1998) 395-398
31. Ng G., and Huang J. The significance of autophagy in cancer. Molecular Carcinogenesis 43 4 (2005) 183-187
32. 3)-and anti-CD95-induced apoptosis in myeloid cells. Erratum appears in FEBS Lett. 2005 Jul 4;579(17):3866. FEBS Letters 578 1-2 (2004) 85-89
33. Ohneseit P.A., Prager D., Kehlbach R., and Rodemann H.P. Cell cycle effects of topotecan alone and in combination with irradiation. Radiotherapy and Oncology 75 2 (2005) 237-245
34. Packer L., Witt E.H., and Tritschler H.J. Alpha-lipoic acid as a biological antioxidant. Free Radical Biology and Medicine 19 2 (1995) 227-250
35. Packer L., Tritschler H.J., and Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radical Biology and Medicine 22 1-2 (1997) 359-378
36. Park W.H., Seol J.G., Kim E.S., Hyun J.M., Jung C.W., Lee C.C., Kim B.K., and Lee Y.Y. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Research 60 11 (2000) 3065-3071
37. Park I.C., Park M.J., Woo S.H., Lee H.C., An S., Gwak H.S., Lee S.H., Hong S.I., Bae I.J., Seo K.M., and Rhee C.H. Tetraarsenic oxide induces apoptosis in U937 leukemic cells through a reactive oxygen species-dependent pathway. International Journal of Oncology 23 4 (2003) 943-948
38. Prestera T., and Talalay P. Electrophile and antioxidant regulation of enzymes that detoxify carcinogens. Proceedings of the National Academy of Sciences of the United States of America 92 19 (1995) 8965-8969
39. Ramos A.M., Fernandez C., Amran D., Sancho P., de Blas E., and Aller P. Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells. Blood 105 10 (2005) 4013-4020
40. Rao M.V., and Avani G. Arsenic induced free radical toxicity in brain of mice. Indian Journal of Experimental Biology 42 5 (2004) 495-498
41. Ratnaike R.N. Acute and chronic arsenic toxicity. Postgraduate Medical Journal 79 933 (2003) 391-396
42. Samuel S., Kathirvel R., Jayavelu T., and Chinnakkannu P. Protein oxidative damage in arsenic induced rat brain: influence of dl-alpha-lipoic acid. Toxicology Letters 155 1 (2005) 27-34
43. 3. International Journal of Molecular Medicine 11 4 (2003) 479-484
44. Shila S., Kokilavani V., Subathra M., and Panneerselvam C. Brain regional responses in antioxidant system to alpha-lipoic acid in arsenic intoxicated rat. Toxicology 210 1 (2005) 25-36
45. Sohal R.S., Ku H.H., Agarwal S., Forster M.J., and Lal H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mechanisms of Ageing and Development 74 1-2 (1994) 121-133
46. Sonneveld P. Effect of alpha-tocopherol on the cardiotoxicity of adriamycin in the rat. Cancer Treatment Reports 62 7 (1978) 1033-1036
47. Talalay P., Fahey J.W., Holtzclaw W.D., Prestera T., and Zhang Y. Chemoprotection against cancer by phase 2 enzyme induction. Toxicology Letters 83 (1995) 173-179
48. Tong Q., Zeng F., Zheng L., Zhao J., and Lu G. Apoptosis inducing effects of arsenic trioxide on human bladder cancer cell line BIU-87. Chinese Medical Journal 114 4 (2001) 402-406
49. Traganos F., and Darzynkiewicz Z. Lysosomal proton pump activity: supravital cell staining with acridine orange differentiates leukocyte subpopulations. Methods in Cell Biology 41 (1994) 185-194
50. Vuky J., Yu R., Schwartz L., and Motzer R.J. Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma. Investigational New Drugs 20 3 (2002) 327-330
51. Wang Z.H., Yu D., Chen Y., and Hao J.Z. Proteomic analysis of nuclear matrix proteins during arsenic trioxide induced apoptosis in leukemia K562 cells. Chinese Medical Journal 118 2 (2005) 100-104
52. Witenberg B., Kalir H.H., Raviv Z., Kletter Y., Kravtsov V., and Fabian I. Inhibition by ascorbic acid of apoptosis induced by oxidative stress in HL-60 myeloid leukemia cells. Biochemical Pharmacology 57 7 (1999) 823-832
53. Woo S.H., Park I.C., Park M.J., Lee H.C., Lee S.J., Chun Y.J., Lee S.H., Hong S.I., and Rhee C.H. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. International Journal of Oncology 21 1 (2002) 57-63
54. Zegura B., Lah T.T., and Filipic M. The role of reactive oxygen species in microcystin-LR-induced DNA damage. Toxicology 200 1 (2004) 59-68
55. Zhang T., Wang S.S., Hong L., Wang X.L., and Qi Q.H. Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo. Journal of Experimental and Clinical Cancer Research 22 1 (2003) 61-68
56. 3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status. International Journal of Oncology 21 1 (2002) 49-55